Levoamphetamine
Names | |
---|---|
Preferred IUPAC name
(2R)-1-Phenylpropan-2-amine | |
Other names
l-Amphetamine, Levamfetamine | |
Identifiers | |
3D model (JSmol) |
|
2432739 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.005.320 |
EC Number |
|
1125855 | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C9H13N | |
Molar mass | 135.2062 g mol−1 |
log P | 1.789 |
Pharmacology | |
Oral (as part of Adderall, Evekeo, and generic amphetamine sulfate) | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
Levoamphetamine is a central nervous system (CNS) stimulant known to increase wakefulness and concentration in association with decreased appetite and fatigue. Pharmaceuticals that contain levoamphetamine are currently indicated and prescribed for the treatment of attention deficit hyperactivity disorder (ADHD), obesity, and narcolepsy in some countries.
Levoamphetamine is the levorotatory stereoisomer of the amphetamine molecule. While pharmaceutical formulations containing enantiopure levoamphetamine are no longer manufactured, levomethamphetamine (levmetamfetamine) is still marketed and sold over-the-counter as a nasal decongestant.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.